Targeting lipid nanoparticles to the blood-brain barrier to ameliorate acute ischemic stroke
Jia Nong(University of Pennsylvania), Oscar A. Marcos‐Contreras(University of Pennsylvania), Tyler E. Papp(Translational Therapeutics (United States)), Sahily Reyes‐Esteves(Vector Oncology (United States)), Marco E. Zamora(Translational Therapeutics (United States)), Barbara L. Mui(Arbutus Biopharma (Canada)), Ashley G. Woolfork(Translational Therapeutics (United States)), Vladimir R. Muzykantov(Translational Therapeutics (United States)), Aalim M. Weljie(University of Pennsylvania), Raisa Y. Kiseleva(Translational Therapeutics (United States)), Hélène C. Descamps, Vladimir V. Shuvaev(California University of Pennsylvania), Serena Omo‐Lamai(University of Pennsylvania), Ying K. Tam(Arbutus Biopharma (Canada)), Evguenia Arguiri(Translational Therapeutics (United States)), Jacob W. Myerson(Translational Therapeutics (United States)), Drew Weissman(California University of Pennsylvania), Mohamad‐Gabriel Alameh(Children's Hospital of Philadelphia), Christoph A. Thaiss(Palo Alto Institute), Hamideh Parhiz(Translational Therapeutics (United States)), Patrick M. Glassman(Translational Therapeutics (United States)), Taylor V. Brysgel(Translational Therapeutics (United States)), Xijing Gong(University of Pennsylvania), Scott E. Kasner(University of Pennsylvania), Ai Wen Tan(Translational Therapeutics (United States)), Tea Shuvaeva(Translational Therapeutics (United States))
Cited by 83
Related Papers
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
|Stroke|2014|5.2k
mRNA vaccines — a new era in vaccinology
|Nature Reviews Drug Discovery|2018|4.4k
An Updated Definition of Stroke for the 21st Century
|Stroke|2013|3.5k
Rational design of cationic lipids for siRNA delivery
|Nature Biotechnology|2010|1.8k